The ESC Handbook on Cardiovascular Pharmacotherapy Second Edition

Punteggio:    0 commenti
Autore: Kaski, Per Kjeldsen
Editore: Oxford University Press
Anno: 2019
Pagine: 960
ISBN: 9780198759935
Prezzo: 61,00€
I prezzi indicati possono subire variazioni poiché soggetti all'oscillazione dei cambi delle valute e/o agli aggiornamenti effettuati dagli Editori.

This European Society of Cardiology (ESC) Handbook on Cardiovascular Pharmacotherapy has been developed by experts from the ESC Working Group on Cardiovascular Pharmacotherapy. Its recommendations are aligned with the ESC Clinical Practice Guidelines and based on the most recent scientific evidence in cardiovascular pharmacology and pharmacotherapy. The Handbook provides up-to-date information on pharmacotherapy for cardiovascular disease prevention, and treatment of cardiovascular disease, including ischaemic heart disease, heart failure, arrhythmias, and structural heart disease. The Handbook also deals with the important problems of cardiovascular pharmacotherapy in pregnancy and lactation, kidney insufficiency, and liver disease as well as focusing on major drug interactions, a topic of extreme importance in clinical practice. Two large sections of the book provide a comprehensive A-Z formulary of cardiac and non-cardiac pharmacological agents with practical and accessible information on the most important pharmacological aspects of these agents and their use in clinical practice.

The Handbook represents essential reading for cardiologists, general practitioners, internal medicine specialists, anaesthetists, clinical pharmacologists, geriatricians, obstetricians, and cardiovascular nurse consultants. Junior doctors and trainees in all these specialties are also likely to find this book of help.

The print edition comes with full access to the online version that will be updated at yearly intervals to keep it up to date.

Section 1: Cardiovascular Disease Prevention, SE: Heinz Drexel, Massimo Piepoli and Josep Perk
1: Hypertension, Robert Zweiker and Sabine Perl
2: Dyslipidaemia, Heinz Drexel
3: Metabolic Syndrome and Diabetes, Christoph Säly
4: Thrombosis, Freek Verheugt
Section 2: Ischaemic Heart Disease, SE: Sven Wassmann and Alexander Niessner
1: Acute Coronary Syndromes, Abhiram Prasad and Claire Raphael
2: Chronic stable angina, Gaetano Antonio Lanza and Antonio De Vita
3: Coronary artery spasm and microvascular angina, Peter Ong and Udo Sechtem
4: Takotsubo Syndrome, Alexander Lyon, Mark Sweeney, and Elmir Omerovic
Section 3: Heart Failure, SE: Faiez Zannad and Theresa McDonagh
1: Heart failure, Faiez Zannad, Joao Pedro Ferreira, and Theresa McDonagh
2: Heart transplantation, Finn Gustafsson and Kasper Rossing
Section 4: Arrhythmias, SE: Antoni Martinez-Rubio and Dan Atar
1: Atrial fibrillation, George Dan and Jan Steffel
2: Supraventricular (narrow complex) tachycardias, Julio Martí
3: Ventricular arrhythmias, Martin Borggrefe, Erol Tülümen, and Josep Brugada
4: Bradyarrhythmias, Haran Burri
5: Syncope, Ricardo Ruiz-Granell
Section 5: Structural heart disease, SE: Claudio Ceconi and Francesca Mantovani
1: Valvular Heart Disease, Francesca Mantovani
2: Myocarditis/ Pericardial Syndromes, Giovanni Boffa and Claudio Ceconi
3: Cardiomyopathy, Giovanni Boffa
4: Pulmonary Hypertension, James Tonkin, Kate Ryan and Brendan Madden
Section 6: Management of cardiovascular disease in pregnancy and lactation and in the presence of co-morbidities, SE: Debasish Banerjee and David Goldsmith
1: Kidney disease, Debasish Banerjee, Robin Ramphul, and David Goldsmith
2: Pregnancy and lactation, Anita Banerjee, Debasish Banerjee, and Vivek Jha
3: Liver disease, Nina Hojs, Aftab Ala, and Debasish Banerjee
Section 7: Major drug interactions, SE: Birgitte Klindt Poulsen and Ljubica Vukelic Andersen
1: Major drug interactions, Maja Hellfritzsch Poulsen and Marlene Lunddal Krogh
Section 8: Cardiovascular drugs from A to Z, SE: Juan Tamargo
1: Cardiovascular drugs from A to Z, Juan Tamargo, Ricardo Caballero and Eva Delpón
Section 9: Non-cardiac drugs affecting the heart - from A to Z, SE: Juan Tamargo
1: Non-cardiac drugs affecting the heart, Eva Delpón and Juan Tamargo

Scrivi una recensione

Il Tuo Nome:

La Tua Recensione: Nota: Il codice HTML non è tradotto!

Punteggio: Negativo             Positivo

Inserisci il codice nel box di seguito: